Refine by
Coronary Interventional Suppliers For Chemical Pharmaceuticals
6 companies found
based inAwans, BELGIUM
Miracor Medical is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System ...
based inSurat, INDIA
SMT is a global medical device company committed to making advance medical technologies accessible to everyone around the world. With a presence in over 69 countries, SMT has achieved recognition from the Government of India for its tremendous ...
Low tip entry profile. Low crossing profile. Quick Inflation & Deflation: SMT's proprietary technology ensures quick deflation (lower deflation time results in reduced ischemic complications). Kink resistant ...
based inLivermore, CALIFORNIA (USA)
Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inMontreal, QUEBEC (CANADA)
QXMedical was founded in 2007 in Montreal, Canada on the principle of providing uncompromised value and quality in underserved high-growth segments of the medical device market. Today, the company is known for its innovative solutions for complex, ...
The QXMédical Boosting Catheter is the next generation guide extension catheter offering an expanded indication for fluid delivery. The Boosting Catheter is designed for use with guiding catheters and sheaths to assist delivery and exchange ...
based in, QUEBEC (CANADA)
Established in 2003, OpSens Medical, a division of OpSens (TSX:OPS), was founded on the belief that our innovative technologies would help to improve cardiovascular disease diagnosis and treatment. Today, our 2nd generation fiber optic OptoWire has ...
OpSens OptoWire is a modern pressure guidewire designed to assess stenoses in vessels such as coronary arteries. OptoWire is powered by Fidela™, a patented 2nd generation fiber optic sensor to measure physiologic indices including ...